Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2020

01-10-2020 | Magnetic Resonance Imaging | ASO Author Reflections

ASO Author Reflections: Breast Cancer Detection of Baseline Screening MRI in High-Risk Women Who Are Not in the Highest Risk Groups

Author: Suzanne B. Coopey, MD

Published in: Annals of Surgical Oncology | Issue 10/2020

Login to get access

Excerpt

Women are understandably nervous about getting breast cancer. With one in eight women developing breast cancer in their lifetime, most women know at least one family member, friend, or colleague with this diagnosis. At the time of the annual screening mammogram, 50% are informed that they have dense breast tissue, resulting in reduced sensitivity of mammography. In addition, routine risk assessment questionnaires are increasingly offered by breast imaging centers, and approximately 16% are found to have elevated lifetime breast cancer risk using the Tyrer–Cuzick model or other models. Suddenly, a woman is told her risk of breast cancer is at least one in five, and she is fearful that this will not be detected by screening mammography. She looks to you for answers. What can you tell this high-risk woman, without a family history suggestive of a genetic mutation, about supplemental screening with breast magnetic resonance imaging (MRI)? This is the question we sought to answer in our article entitled “Baseline screening MRI uptake and findings in women with ≥ 20% lifetime risk of breast cancer”.1
Literature
1.
go back to reference Laws A, Mulvey TM, Jalbert N, Dalton S, Kantor O, Harris KA, et al. Baseline screening MRI update and findings in women with ≥ 20% lifetime risk of breast cancer. Ann Surg Oncol (in press). Laws A, Mulvey TM, Jalbert N, Dalton S, Kantor O, Harris KA, et al. Baseline screening MRI update and findings in women with ≥ 20% lifetime risk of breast cancer. Ann Surg Oncol (in press).
2.
go back to reference Marinovich ML, Hunter KE, Macaskill P, Houssami N. Breast cancer screening using tomosynthesis or mammography: a meta-analysis of cancer detection and recall. J Natl Cancer Inst. 2018;110:942–9.CrossRef Marinovich ML, Hunter KE, Macaskill P, Houssami N. Breast cancer screening using tomosynthesis or mammography: a meta-analysis of cancer detection and recall. J Natl Cancer Inst. 2018;110:942–9.CrossRef
3.
go back to reference Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology. 2017;283:361–70.CrossRef Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology. 2017;283:361–70.CrossRef
4.
go back to reference Berg WA, Zhang Z, Lehrer, et al.; for the ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307:1394–404. Berg WA, Zhang Z, Lehrer, et al.; for the ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307:1394–404.
Metadata
Title
ASO Author Reflections: Breast Cancer Detection of Baseline Screening MRI in High-Risk Women Who Are Not in the Highest Risk Groups
Author
Suzanne B. Coopey, MD
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08722-0

Other articles of this Issue 10/2020

Annals of Surgical Oncology 10/2020 Go to the issue